实用医学杂志2017，Vol.33Issue(3)：447-450,4.DOI:10.3969/j.issn.1006-5725.2017.03.031
冠心病合并糖尿病患者氯吡格雷抵抗分析及随访
The analysis and follow-up study of Clopidogrel resistance of Coronary heart disease combine with diabetes patients
摘要
Abstract
Objective To analyze Clopidogrel Resistance (CR) and influencing factors of coronary heart disease (CHD) with diabetes (DM) patients and evaluatc the relationship of CR and major adverse cardiovascular events (MACE) and readmission of CHD with DM patients.Methods 270 CHD patients were enrolled.Clinical conditions of CR were measured by adenosine diphosphate (ADP) induced maximum platelet aggregation rate (MPAR).After 1-year follow-up,MACE events and rehospitalization were recorded.Results CR of NDM and DM patients were 45 (33.1％) and 78 cases (58.2％) respectively,and the difference was significant (P ＜ 0.001).Factors of CR of CHD DM patients included heart rate,TG level,the number of severe coronary artery disease.MACE events of CS and CR patients were 35 (23.8％) and 47 patients (38.2％) respectively,and the difference was significant (P =0.010).The readmitted patients of CS and CR groups were 15 cases (10.2％) and 27 patients (22.0％) respectively,and the differcnce was significant (P =0.008).The MACE of CR and CS patients in DM group were 32 (41.0％) and 12 cases (21.4％) respectively,and thc difference was significant (P ＜ 0.05).The Readmitted cases of CR and CS patients in DM group were 19 (24.4％) and 5 (8.9％) respectively,and the diffcrcnce was significant (P ＜ 0.05).Conclusions CR of CHD DM patients increased significantly.The influencing factors of CR of CHDDM are including heart rate,TG level,the number of severe coronary artery disease.MACE events and rehospitalization rate were significantly increased in CHD patients with DM AR.Therefore,it should be further strengthened the anti-platelet therapy for CHD patients with DM.关键词
冠心痛/糖尿病/氯吡格雷抵抗/分析/随访研究Key words
Coronary heart disease combine with diabetes/Clopidogrel Resistance/Analysis/Follow-up study引用本文复制引用
王志军,王泽宇,王硕,周建芝,刘宁,刁增利,黄宇玲,刘铁楠,李海涛..冠心病合并糖尿病患者氯吡格雷抵抗分析及随访[J].实用医学杂志,2017,33(3):447-450,4.基金项目
河北省卫生厅医学研究重点课题计划项目(编号:20100474) （编号:20100474）
